|
1
|
Wahid F, Shehzad A, Khan T, et al:
Micrornas: Synthesis, mechanism, function, and recent clinical
trials. Biochim Biophys Acta. 1803:1231–1243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calin GA, Liu CG, Sevignani C, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Michael MZ, O’Connor SM, van Holst
Pellekaan NG, et al: Reduced accumulation of specific microRNAs in
colorectal neoplasia. Mol Cancer Res. 1:882–891. 2003.PubMed/NCBI
|
|
5
|
Roldo C, Missiaglia E, Hagan JP, et al:
MicroRNA expression abnormalities in pancreatic endocrine and
acinar tumors are associated with distinctive pathologic features
and clinical behavior. J Clin Oncol. 24:4677–4684. 2006. View Article : Google Scholar
|
|
6
|
Bernstein E, Caudy AA, Hammond SM, et al:
Role for a bidentate ribonuclease in the initiation step of RNA
interference. Nature. 409:363–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar MS, Lu J, Mercer KL, et al: Impaired
microRNA processing enhances cellular transformation and
tumorigenesis. Nat Genet. 39:673–677. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mezzanzanica D, Bagnoli M, De Cecco L, et
al: Role of microRNAs in ovarian cancer pathogenesis and potential
clinical implications. Int J Biochem Cell Biol. 42:1262–1272. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Merritt WM, Lin YG, Han LY, et al: Dicer,
drosha, and outcomes in patients with ovarian cancer. N Engl J Med.
359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simon JA and Lange CA: Roles of the EZH2
histone methyltransferase in cancer epigenetics. Mutat Res.
647:21–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taniguchi H, Jacinto FV, Villanueva A, et
al: Silencing of Kruppel-like factor 2 by the histone
methyltransferase EZH2 in human cancer. Oncogene. 31:1988–1994.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang J, Zhang MX and Li QL: Enhancer of
zeste homolog 2 expression is associated with tumor cell
proliferation and invasion in cervical cancer. Am J Med Sci.
342:198–204. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo JF, Cai J, Yu LL, et al: EZH2
regulates expression of p57 and contributes to progression of
ovarian cancer in vitro and in vivo. Cancer Science.
102:530–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noh H, Hong S, Dong Z, et al: Impaired
microRNA processing facilitates breast cancer cell invasion by
upregulating urokinase-type plasminogen activator expression. Genes
Cancer. 2:140–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang KF, Song GB, Shi YS, et al: Dicer
knockdown induces fibronectin-1 expression in HEK293T cells via
induction of Egr1. Biochim Biophys Acta. 1800:380–384. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han L, Zhang A, Zhou X, et al:
Downregulation of Dicer enhances tumor cell proliferation and
invasion. Int J Oncol. 37:299–305. 2010.PubMed/NCBI
|
|
17
|
Kumar MS, Lu J, Mercer KL, et al: Impaired
microRNA processing enhances cellular transformation and
tumorigenesis. Nat Genet. 39:673–677. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McLoughlin HS, Fineberg SK, Ghosh LL, et
al: Dicer is required for proliferation, viability, migration and
differentiation in corticoneurogenesis. Neuroscience. 223:285–295.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Faggad A, Budczies J, Tchernitsa O, et al:
Prognostic significance of Dicer expression in ovarian cancer-link
to global microRNA changes and oestrogen receptor expression. J
Pathol. 220:382–391. 2010.PubMed/NCBI
|
|
20
|
Bu Y, Lu C, Bian C, et al: Knockdown of
Dicer in MCF-7 human breast carcinoma cells results in G1 arrest
and increased sensitivity to cisplatin. Oncol Rep. 21:13–17.
2009.PubMed/NCBI
|
|
21
|
Tokumaru S, Suzuki M, Yamada H, et al:
Let-7 regulates Dicer expression and constitutes a negative
feedback loop. Carcinogenesis. 29:2073–2077. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wiesen JL and Tomasi TB: Dicer is
regulated by cellular stresses and interferons. Mol Immunol.
46:1222–1228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu S, Yu L, Li Z, Shen Y, et al:
Overexpression of EZH2 contributes to acquired cisplatin resistance
in ovarian cancer cells in vitro and in vivo. Cancer
Biol Ther. 10:788–795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔ C (T)) Method. Methods. 25:402–408. 2001.
|
